Free Trial

Longboard Pharmaceuticals (LBPH) Insider Trading & Ownership

Longboard Pharmaceuticals logo
$59.98 +0.02 (+0.03%)
(As of 12/2/2024)

Longboard Pharmaceuticals (NASDAQ:LBPH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.64%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$2,482.00
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$98.57 M
Get LBPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Longboard Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LBPH Insider Buying and Selling by Quarter

Longboard Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/15/2024Randall KayeCMOSell16,667$59.03$983,853.01  
9/16/2024Randall KayeCMOSell16,666$31.64$527,312.24  
8/12/2024Randall KayeCMOSell16,667$34.73$578,844.91  
6/25/2024Randall KayeCMOSell100$20.87$2,087.00  
1/25/2024Arena Pharmaceuticals IncMajor ShareholderSell3,978,540$24.25$96,479,595.00  
1/23/2024Randall KayeCMOBuy100$24.82$2,482.00  
(Data available from 1/1/2013 forward)

LBPH Insider Trading Activity - Frequently Asked Questions

The list of insiders at Longboard Pharmaceuticals includes Arena Pharmaceuticals Inc, and Randall Kaye. Learn more on insiders at LBPH.

4.64% of Longboard Pharmaceuticals stock is owned by insiders. Learn more on LBPH's insider holdings.

The following insider purchased LBPH shares in the last 24 months: Randall Kaye ($2,482.00).

Insiders have purchased a total of 100 LBPH shares in the last 24 months for a total of $2,482.00 bought.

The following insiders have sold LBPH shares in the last 24 months: Arena Pharmaceuticals Inc ($96,479,595.00), and Randall Kaye ($2,092,097.16).

Insiders have sold a total of 4,028,640 Longboard Pharmaceuticals shares in the last 24 months for a total of $98,571,692.16 sold.

Longboard Pharmaceuticals Key Executives

  • Mr. Kevin R. Lind (Age 48)
    President, CEO, Secretary & Director
    Compensation: $1.07M
  • Ms. Brandi L. Roberts CPA (Age 50)
    M.B.A., Executive VP & CFO
    Compensation: $662.65k
  • Dr. Randall E. Kaye M.D. (Age 62)
    Executive VP & Chief Medical Officer
    Compensation: $717.95k
  • Mr. Chadwick J. Orevillo MPH
    Executive VP & Head of Operations
  • Megan E. Knight
    VP & Head of Investor Relations
  • Mr. Steven W. Spector J.D. (Age 59)
    Executive VP, Head of Business Development & General Counsel
  • Dr. Anne M. Danks Ph.D.
    VP & Head of Nonclinical Research & Development
  • Mr. Gus Cardenas
    VP & Head of Quality Assurance
  • Dr. Marco Peters Ph.D.
    VP & Head of Translational Science
  • Dr. Dewey McLin Ph.D.
    VP & Head of Medical Affairs


This page (NASDAQ:LBPH) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners